PROTAGONIST THERAPEUTICS, INC (PTGX)
Director Giraudo Bryan 🟡 adjusted position in 59.1K shares (2 derivative) of Protagonist Therapeutics, Inc (PTGX) at $100.14 ($6.4M) Transaction Date: May 07, 2026 | Filing ID: 058860
Director Giraudo Bryan 🟡 adjusted position in 59.1K shares (2 derivative) of Protagonist Therapeutics, Inc (PTGX) at $100.14 ($6.4M) Transaction Date: May 07, 2026 | Filing ID: 058860
🔍 Giraudo Bryan (Director)
Company: Protagonist Therapeutics, Inc (PTGX)
Report Date: 2026-05-07
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,825.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,825.00 | transaction_form_type: 4
Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,825.00 | transaction_form_type: 4 | Footnotes: F2
Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,695.00 | transaction_form_type: 4
Date: 2026-05-07 | Code: M | Expires: 2028-05-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
Date: 2026-05-07 | Code: M | Expires: 2028-05-28 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
Footnotes: